Certified by Founder Lodge
Avoro Capital Advisors
United States - New York
INVESTOR
1 Disclosed Funding Rounds $135,000,000
2 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Global life sciences firm focused on investments in biotechnology and specialty therapeutics.
| Company | Date | Round | Raised |
|---|---|---|---|
 Hemab Therapeutics |
February, 22 ,2023 | Series B | $135,000,000 |
 Vicebio |
September, 24 ,2024 | Series B | $100,000,000 |
dezerv.
FalconX
Kristal.AI
Finary
Savart
Jupid | $840,000 | (May 1, 2026)
DISA Technologies, Inc. | $33,000,000 | (May 1, 2026)
Blomma | $5,000,000 | (May 1, 2026)
Illuminant Surgical | $8,400,000 | (May 1, 2026)
Dreambase | $3,700,000 | (May 1, 2026)
